Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Montalescot

Showing results (51-60 of 143) with videos related to

Pageof 15
Sort By:
Annales De Cardiologie Et D'Angeiologie|February 3, 2004
[Role of glycoprotein IIb/IIIa inhibitors in the management of acute coronary syndromes]R Choussat, J P Collet, F Beygui, et al.
International Journal of Cardiology|March 15, 2000
A rise of troponin and/or von Willebrand factor over the first 48 h is associated with a poorer 1-year outcome in unstable angina patientsG Montalescot, J P Collet, R Choussat, et al.
International Journal of Cardiology|September 29, 2001
Enoxaparin in unstable angina patients with renal failureJ P Collet, G Montalescot, R Choussat, et al.
Annales De Cardiologie Et D'Angeiologie|October 20, 2012
[Management of ST-elevation myocardial infarction in 2012]G Cayla, J Silvain, P Ecollan, et al.
QJM : Monthly Journal of the Association of Physicians|May 1, 2012
Current antiplatelet options for NSTE-ACS patientsG Cayla, J Silvain, S A O'Connor, et al.
Catheterization and Cardiovascular Diagnosis|April 1, 1992
Systemic embolism as a complication of percutaneous mitral valvuloplastyG Drobinski, G Montalescot, J Evans, et al.
International Journal of Cardiology|August 1, 1988
Diagnosis of primary cardiac sarcoma. Report of 4 cases and review of the literatureG Montalescot, C Chapelon, G Drobinski, et al.
Journal Des Maladies Vasculaires|October 27, 2001
[Whole blood viscosity measurement in acute myocardial infarction: feasibility and significance]F Philippe, C Lacombe, C Bucherer, et al.
Journal of the American College of Cardiology|July 1, 1994
Eicosanoid biosynthesis in patients with stable angina: beneficial effects of very low dose aspirinG Montalescot, J Maclouf, G Drobinski, et al.
Circulation|July 1, 1995
Fibrinogen after coronary angioplasty as a risk factor for restenosisG Montalescot, A Ankri, E Vicaut, et al.
Pageof 15

Showing results (51-60 of 143) with videos related to

Sort By:
Pageof 15
Annales De Cardiologie Et D'Angeiologie|February 3, 2004
[Role of glycoprotein IIb/IIIa inhibitors in the management of acute coronary syndromes]R Choussat, J P Collet, F Beygui, et al.
International Journal of Cardiology|March 15, 2000
A rise of troponin and/or von Willebrand factor over the first 48 h is associated with a poorer 1-year outcome in unstable angina patientsG Montalescot, J P Collet, R Choussat, et al.
International Journal of Cardiology|September 29, 2001
Enoxaparin in unstable angina patients with renal failureJ P Collet, G Montalescot, R Choussat, et al.
Annales De Cardiologie Et D'Angeiologie|October 20, 2012
[Management of ST-elevation myocardial infarction in 2012]G Cayla, J Silvain, P Ecollan, et al.
QJM : Monthly Journal of the Association of Physicians|May 1, 2012
Current antiplatelet options for NSTE-ACS patientsG Cayla, J Silvain, S A O'Connor, et al.
Catheterization and Cardiovascular Diagnosis|April 1, 1992
Systemic embolism as a complication of percutaneous mitral valvuloplastyG Drobinski, G Montalescot, J Evans, et al.
International Journal of Cardiology|August 1, 1988
Diagnosis of primary cardiac sarcoma. Report of 4 cases and review of the literatureG Montalescot, C Chapelon, G Drobinski, et al.
Journal Des Maladies Vasculaires|October 27, 2001
[Whole blood viscosity measurement in acute myocardial infarction: feasibility and significance]F Philippe, C Lacombe, C Bucherer, et al.
Journal of the American College of Cardiology|July 1, 1994
Eicosanoid biosynthesis in patients with stable angina: beneficial effects of very low dose aspirinG Montalescot, J Maclouf, G Drobinski, et al.
Circulation|July 1, 1995
Fibrinogen after coronary angioplasty as a risk factor for restenosisG Montalescot, A Ankri, E Vicaut, et al.
Pageof 15